Skip to main content

Nemes Rush Group LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1982273 NOVI, MI

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,004
+$4,564 QoQ
Shares Held
700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#229
of 293 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nemes Rush Group LLC holds $3,327,523 across 17 Biotechnology names. DNLI ranks #6 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 DNLI
Denali Therapeutics Inc.
This page
700 $18,004

All Filings in DNLI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,004 700
2026-03-31 $13,440 700
2025-12-31 $11,557 700
2025-09-30 $10,164 700
2025-06-30 $9,793 700
2025-03-31 $9,516 700
2024-12-31 $14,266 700
2024-09-30 $20,391 700
2024-06-30 $16,254 700
2024-03-31 $14,364 700
2023-12-31 $15,022 700
2023-09-30 $14,441 700
2023-06-30 $20,657 700